IP Library Granted Patent US 8,632,988
Granted Patent B1
US 8,632,988 · App. 13/333,798 · Granted Jan 21, 2014

Pathogen hemoglobin receptor specificity for human hemoglobin

Inventors: Eric P. Skaar (Brentwood, TN); Glib Pishchany (Antioch, TN)
Assignee: Vanderbilt University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,632,988
App. No.
13/333,798
Granted
Jan 21, 2014
Kind
B1
Abstract

A method of measuring binding between hemoglobin and a microbe of interest includes: providing hemoglobin from a source of interest; contacting the hemoglobin with a microbe of interest; and measuring the binding affinity between the hemoglobin and the microbe, wherein the binding affinity is indicative of microbe virulence in the presence of the hemoglobin.

Claims (8)

1. A method of screening a mammalian subject for susceptibility to systemic infection by Staphylococcus aureus comprising:

(a) providing purified hemoglobin from the subject;

(b) contacting the hemoglobin with the Staphylococcus aureus and

(c) measuring the binding affinity between the hemoglobin and the Staphylococcus aureus , wherein an increased binding affinity between the hemoglobin and the Staphylococcus aureus compared to the binding affinity between the hemoglobin and a control is indicative of the enhanced susceptibility of the subject to the Staphylococcus aureus , wherein the control is an average of binding affinities between the Staphylococcus aureus and purified hemoglobin from a predetermined population of the mammalian subject.

2. The method of claim 1 , wherein the subject is human.

3. The method of claim 1 , wherein the increased binding affinity is indicative of iron acquisition by the Staphylococcus aureus.

4. The method of claim 1 , wherein the increased binding affinity is indicative of risk of developing the infection by the subject.

5. The method of claim 1 , wherein the increased binding affinity is indicative of risk of developing the exacerbated infection by the subject.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 13, 2017
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042683/0038 →
CONFIRMATORY LICENSE Recorded Dec 14, 2016
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040734/0300 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2012
From: SKAAR, ERIC P.; PISHCHANY, GLIB
To: VANDERBILT UNIVERSITY
Reel/Frame 027559/0978 →
Continuity (1)
Provisional Application 61425588 · Dec 21, 2010